We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
+12.22%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$212M
AUM Growth
+$3.81M
Cap. Flow
-$14.4M
Cap. Flow %
-6.8%
Top 10 Hldgs %
75.52%
Holding
61
New
5
Increased
12
Reduced
13
Closed
1

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$23.8M
2
ENB icon
Enbridge
ENB
+$503K
3
LHX icon
L3Harris
LHX
+$501K
4
AMZN icon
Amazon
AMZN
+$443K
5
ILMN icon
Illumina
ILMN
+$405K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$41.3M
2
IDXX icon
Idexx Laboratories
IDXX
+$174K
3
GE icon
GE Aerospace
GE
+$152K
4
VZ icon
Verizon
VZ
+$124K
5
PFE icon
Pfizer
PFE
+$119K

Sector Composition

Rank Sector Weight
1 Technology 40.99%
2 Healthcare 33.84%
3 Communication Services 10.02%
4 Consumer Discretionary 4.46%
5 Industrials 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SO icon
51
Southern Company
SO
$106B
$250K 0.12%
3,931
– –
TSLA icon
52
Tesla
TSLA
$1.26T
$247K 0.12%
+8,850
New +$192K
ED icon
53
Consolidated Edison
ED
$39.9B
$240K 0.11%
2,650
– –
IBM icon
54
IBM
IBM
$220B
$231K 0.11%
1,799
-453
-20% -$58.9K
ABT icon
55
Abbott
ABT
$185B
$223K 0.11%
2,568
– –
JPM icon
56
JPMorgan Chase
JPM
$947B
$209K 0.1%
+1,500
New +$192K
INTU icon
57
Intuit
INTU
$87.9B
$208K 0.1%
793
+1
+0.1% +$261
RIO icon
58
Rio Tinto
RIO
$162B
$202K 0.1%
+3,400
New +$184K
VTAK icon
59
Catheter Precision
VTAK
$962K
$202K 0.1%
+1
New +$305K
GE icon
60
GE Aerospace
GE
$388B
$119K 0.06%
2,139
-2,945
-58% -$152K
CELG
61
DELISTED
Celgene Corp
CELG
– –
-415,615
Closed -$41.3M
1 2
3

Similar funds

PIA
PineBridge Investments Asia Hong Kong $289M AUM
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
GIM
Goodlander Investment Management Dallas, Texas $289M AUM 225.62% 1-Year Est. Return
PSA
Plum Street Advisors New Orleans, Louisiana $289M AUM 17.28% 1-Year Est. Return
SI
Saxon Interests Houston, Texas $290M AUM 19.97% 1-Year Est. Return
FFA
Fairfield Financial Advisors Wellesley, Massachusetts $290M AUM 15.81% 1-Year Est. Return
OCM
Orion Capital Management Coronado, California $290M AUM 17.97% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Bourne Lent Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Bourne Lent Asset Management held 61 positions worth $212M, up 1.8% from $209M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bourne Lent Asset Management withdrew a net $14.4M in Q4 2019, closing 1 position and reducing 13 holdings. Its most notable exit was Celgene Corp, an estimated $41.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 36% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Bourne Lent Asset Management opened a new position in Gilead Sciences worth $354K.

  • Bourne Lent Asset Management's largest Q4 2019 buy was Gilead Sciences: 5,455 shares worth $354K.
  • Bourne Lent Asset Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $23.8M increase.
  • Bourne Lent Asset Management's biggest Q4 2019 reduction was Idexx Laboratories, cutting an estimated $174K.
  • Bourne Lent Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $41.3M.
  • Bourne Lent Asset Management's ten largest holdings make up 76% of its $212M portfolio in Q4 2019.
  • Bourne Lent Asset Management opened 5 new positions and closed 1 in Q4 2019.
  • Bourne Lent Asset Management's portfolio value rose 1.8% quarter-over-quarter to $212M.

Based on Bourne Lent Asset Management's 13F filing for Q4 2019, filed 24 Jan 2020.